| 000 | 01708 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513115819.0 | ||
| 264 | 0 | _c19970630 | |
| 008 | 199706s 0 0 eng d | ||
| 022 | _a0305-7453 | ||
| 024 | 7 |
_a10.1093/jac/39.4.509 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChoi, K H | |
| 245 | 0 | 0 |
_aIn-vitro and in-vivo activities of DW-116, a new fluoroquinolone. _h[electronic resource] |
| 260 |
_bThe Journal of antimicrobial chemotherapy _cApr 1997 |
||
| 300 |
_a509-14 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xpharmacology |
| 650 | 0 | 4 |
_aBacterial Infections _xprevention & control |
| 650 | 0 | 4 |
_aCiprofloxacin _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEnterococcus faecalis _xdrug effects |
| 650 | 0 | 4 | _aFluoroquinolones |
| 650 | 0 | 4 |
_aGram-Negative Bacteria _xdrug effects |
| 650 | 0 | 4 |
_aGram-Positive Bacteria _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMethicillin Resistance |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred ICR |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aOfloxacin _xpharmacology |
| 650 | 0 | 4 |
_aPiperazines _xpharmacology |
| 650 | 0 | 4 |
_aPseudomonas aeruginosa _xdrug effects |
| 650 | 0 | 4 |
_aQuinolones _xpharmacology |
| 650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
| 700 | 1 | _aHong, J S | |
| 700 | 1 | _aKim, S K | |
| 700 | 1 | _aLee, D K | |
| 700 | 1 | _aYoon, S J | |
| 700 | 1 | _aChoi, E C | |
| 773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 39 _gno. 4 _gp. 509-14 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/39.4.509 _zAvailable from publisher's website |
| 999 |
_c9127202 _d9127202 |
||